市場調查報告書

代謝體學的全球市場:未來展望

Global Metabolomics Market Forecast 2019-2027

出版商 Inkwood Research 商品編碼 915982
出版日期 內容資訊 英文 188 Pages
商品交期: 2-3個工作天內
價格
Back to Top
代謝體學的全球市場:未來展望 Global Metabolomics Market Forecast 2019-2027
出版日期: 2019年11月08日內容資訊: 英文 188 Pages
簡介

本報告提供全球代謝體學市場未來展望相關分析,技術的特性和市場基本結構,主要的促進、阻礙因素,市場整體及各產品/服務、各用途、各症狀、各地區的市場趨勢預測 (今後9年份),主要企業簡介等調查。

第1章 分析範圍

第2章 分析方法

第3章 摘要整理

第4章 市場動態

  • 市場定義和範圍
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第5章 各產品、服務的市場

  • 代謝體學設備
    • 分離工具
      • 高效液相層析
      • 氣相層析法
      • 超高效液相層析
      • 毛細管電泳法 (CE)
    • 檢測工具
      • 質譜分析 (MS)
      • 核磁共振光譜學 (NMRS)
      • 表面質譜分析 (surface-based mass analysis)
  • 代謝體學、生物資訊學用工具/服務

第6章 各用途的市場

  • 生物標誌物的發現
  • 藥物研發
  • 毒性實驗
  • 營養基因學
  • 功能基因學
  • 個人化醫療
  • 其他

第7章 各症狀的市場

  • 癌症
  • 心血管疾病
  • 神經疾病
  • 先天性代謝異常 (IEM)
  • 其他

第8章 主要分析指標

  • 波特的五力分析
  • 價值鏈分析
  • 市場趨勢
  • 市場機會矩陣

第9章 各地區分析

  • 北美 (美國,加拿大)
  • 歐洲 (德國,法國,英國,義大利,西班牙等)
  • 亞太地區 (日本,中國,澳洲,印度,韓國等)
  • 其他的國家 (RoW:南美,中東、非洲)

第10章 競爭環境

  • 市場定位分析
  • 企業簡介
    • AGILENT TECHNOLOGIES, INC.
    • APICAL SCIENTIFIC SDN BHD
    • BIOCRATES LIFE SCIENCES AG
    • BIO-RAD LABORATORIES, INC.
    • BRUKER CORPORATION
    • CREATIVE PROTEOMICS
    • DANAHER CORPORATION (SCIEX)
    • HUMAN METABOLOME TECHNOLOGIES, INC.
    • KORE TECHNOLOGY LIMITED
    • LECO CORPORATION
    • METABOLON INC.
    • PERKINELMER, INC.
    • 島津製作所
    • THERMO FISHER SCIENTIFIC INC.
    • WATERS CORPORATION
目錄
Product Code: 28115

KEY FINDINGS

The global metabolomics market is predicted to showcase growth at a CAGR of 11.84% during the projected period. The surging chronic diseases, along with the prevalence of cancer, are the major factors influencing the growth of the global market of metabolomics.

MARKET INSIGHTS

The report includes the segmentation on the basis of application, indication, and product & service. The use of metabolomics in studying cancer would be instrumental as it would result in new biomarkers for cancer, which are further used in the diagnosis of the disease. Also, advancements in personalized medicine aids in a scientific understanding of diseases like cancer and genetic diseases. The development of methodologies has always been given preference when it comes to research activities in nutrition. This is set to result in huge market growth opportunities in the global metabolomics market. The metabolomics incurs huge costs in terms of instrumentation, and this factor can limit the market growth.

REGIONAL INSIGHTS

The global market with regard to metabolomics is analyzed on the basis of North America, Europe, Asia Pacific, and the Rest of the World. The North American market region is projected to garner the largest market share by the end of the forecast period. The region has a large presence of several end-users. The market region of Asia Pacific is estimated to record the highest CAGR for the metabolomics market. The growth is attributed to the presence of economically diverse countries in the region.

COMPETITIVE INSIGHTS

The market has the presence of key players that aid in the growth and revenue of the market. Some of the key players include, Bruker Corporation, Danaher Corporation (Sciex), Bio-Rad Laboratories, Inc., Biocrates Life Sciences Ag, Creative Proteomics, Apical Scientific Sdn Bhd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
    • 3.2.2. BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
    • 3.2.3. CANCER IS THE MOST PREVALENT INDICATION

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
    • 4.2.2. RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
    • 4.2.3. UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
    • 4.3.2. HIGH COST OF THE INSTRUMENTS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
    • 4.4.2. GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES

5. MARKET BY PRODUCT & SERVICE

  • 5.1. METABOLOMICS INSTRUMENTS
    • 5.1.1. SEPARATION TECHNIQUE
      • 5.1.1.1. HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
      • 5.1.1.2. GAS CHROMATOGRAPHY
      • 5.1.1.3. ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY
      • 5.1.1.4. CAPILLARY ELECTROPHORESIS
    • 5.1.2. DETECTION TECHNIQUE
      • 5.1.2.1. MASS SPECTROMETRY
      • 5.1.2.2. NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
      • 5.1.2.3. SURFACE-BASED MASS ANALYSIS
  • 5.2. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES

6. MARKET BY APPLICATION

  • 6.1. BIOMARKER DISCOVERY
  • 6.2. DRUG DISCOVERY
  • 6.3. TOXICOLOGY TESTING
  • 6.4. NUTRIGENOMICS
  • 6.5. FUNCTIONAL GENOMICS
  • 6.6. PERSONALIZED MEDICINE
  • 6.7. OTHER APPLICATION

7. MARKET BY INDICATION

  • 7.1. CANCER
  • 7.2. CARDIOVASCULAR DISORDERS
  • 7.3. NEUROLOGICAL DISORDERS
  • 7.4. INBORN ERRORS OF METABOLISM
  • 7.5. OTHER INDICATION

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. VALUE CHAIN ANALYSIS
  • 8.3. MARKET TRENDS
  • 8.4. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. JAPAN
    • 9.3.2. CHINA
    • 9.3.3. AUSTRALIA
    • 9.3.4. INDIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET POSITION ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. AGILENT TECHNOLOGIES, INC.
    • 10.2.2. APICAL SCIENTIFIC SDN BHD
    • 10.2.3. BIOCRATES LIFE SCIENCES AG
    • 10.2.4. BIO-RAD LABORATORIES, INC.
    • 10.2.5. BRUKER CORPORATION
    • 10.2.6. CREATIVE PROTEOMICS
    • 10.2.7. DANAHER CORPORATION (SCIEX)
    • 10.2.8. HUMAN METABOLOME TECHNOLOGIES, INC.
    • 10.2.9. KORE TECHNOLOGY LIMITED
    • 10.2.10. LECO CORPORATION
    • 10.2.11. METABOLON INC.
    • 10.2.12. PERKINELMER, INC.
    • 10.2.13. SHIMADZU CORPORATION
    • 10.2.14. THERMO FISHER SCIENTIFIC INC.
    • 10.2.15. WATERS CORPORATION

LIST OF TABLES

  • TABLE 1: GLOBAL METABOLOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 2: GLOBAL METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 3: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 4: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 5: GLOBAL SEPARATION TECHNIQUE MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 6: GLOBAL DETECTION TECHNIQUE MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 7: GLOBAL METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 8: GLOBAL METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 9: GLOBAL BIOMARKER DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 10: GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 11: GLOBAL TOXICOLOGY TESTING MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 12: GLOBAL NUTRIGENOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 13: GLOBAL FUNCTIONAL GENOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 14: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 15: GLOBAL OTHER APPLICATION MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 16: GLOBAL METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 17: GLOBAL CANCER MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 18: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 19: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 20: GLOBAL INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 21: GLOBAL OTHER INDICATION MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 22: GLOBAL METABOLOMICSMARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 23: NORTH AMERICA METABOLOMICSMARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 24: THE UNITED STATES METABOLOMICSMARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 25: THE UNITED STATES METABOLOMICSMARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 26: THE UNITED STATES METABOLOMICSMARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 27: CANADA METABOLOMICSMARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 28: CANADA METABOLOMICSMARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 29: CANADA METABOLOMICSMARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 30: EUROPE METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 31: GERMANY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 32: GERMANY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 33: GERMANY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 34: FRANCE METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 35: FRANCE METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 36: FRANCE METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 37: THE UNITED KINGDOM METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 38: THE UNITED KINGDOM METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 39: THE UNITED KINGDOM METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 40: ITALY METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 41: ITALY METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 42: ITALY METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 43: SPAIN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 44: SPAIN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 45: SPAIN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 46: ASIA-PACIFIC METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 47: JAPAN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 48: JAPAN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 49: JAPAN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 50: CHINA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 51: CHINA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 52: CHINA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 53: AUSTRALIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 54: AUSTRALIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 55: AUSTRALIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 56: INDIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 57: INDIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 58: INDIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 59: SOUTH KOREA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
  • TABLE 60: SOUTH KOREA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 61: SOUTH KOREA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
  • TABLE 62: REST OF WORLD METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 63: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

LIST OF FIGURES

  • FIGURE 1: GLOBAL METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 2: GLOBAL METAGENOMICS MARKET SHARE, BY PRODUCT & SERVICE, 2018 & 2027 (%)
  • FIGURE 3: GLOBAL METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)
  • FIGURE 4: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)
  • FIGURE 5: GLOBAL SEPARATION TECHNIQUE MARKET, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, 2019-2027 ($ MILLION)
  • FIGURE 6: GLOBAL SEPARATION TECHNIQUE MARKET, BY GAS CHROMATOGRAPHY, 2019-2027 ($ MILLION)
  • FIGURE 7: GLOBAL SEPARATION TECHNIQUE MARKET, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, 2019-2027 ($ MILLION)
  • FIGURE 8: GLOBAL SEPARATION TECHNIQUE MARKET, BY CAPILLARY ELECTROPHORESIS, 2019-2027 ($ MILLION)
  • FIGURE 9: GLOBAL METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)
  • FIGURE 10: GLOBAL DETECTION TECHNIQUE MARKET, BY MASS SPECTROMETRY, 2019-2027 ($ MILLION)
  • FIGURE 11: GLOBAL DETECTION TECHNIQUE MARKET, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2019-2027 ($ MILLION)
  • FIGURE 12: GLOBAL DETECTION TECHNIQUE MARKET, BY SURFACE-BASED MASS ANALYSIS, 2019-2027 ($ MILLION)
  • FIGURE 13: GLOBAL METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 14: GLOBAL METABOLOMICS MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
  • FIGURE 15: GLOBAL METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)
  • FIGURE 16: GLOBAL METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)
  • FIGURE 17: GLOBAL METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)
  • FIGURE 18: GLOBAL METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)
  • FIGURE 19: GLOBAL METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)
  • FIGURE 20: GLOBAL METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)
  • FIGURE 21: GLOBAL METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)
  • FIGURE 22: GLOBAL METABOLOMICS MARKET SHARE, BY INDICATION, 2018 & 2027 (%)
  • FIGURE 23: GLOBAL METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)
  • FIGURE 24: GLOBAL METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)
  • FIGURE 25: GLOBAL METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)
  • FIGURE 26: GLOBAL METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)
  • FIGURE 27: GLOBAL METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)
  • FIGURE 28: PORTER'S FIVE FORCE MODEL
  • FIGURE 29: GLOBAL METABOLOMICSMARKET, REGIONAL OUTLOOK, 2018 & 2027 (%)
  • FIGURE 30: THE UNITED STATES METABOLOMICSMARKET, 2019-2027 ($ MILLION)
  • FIGURE 31: CANADA METABOLOMICSMARKET, 2019-2027 ($ MILLION)
  • FIGURE 32: GERMANY METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 33: FRANCE METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 34: THE UNITED KINGDOM METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 35: ITALY METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 36: SPAIN METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 37: REST OF EUROPE METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 38: JAPAN METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 39: CHINA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 40: AUSTRALIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 41: INDIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 42: SOUTH KOREA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 43: REST OF ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 44: LATIN AMERICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
  • FIGURE 45: MIDDLE EAST AND AFRICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
Back to Top